A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea

European Journal of Clinical Nutrition

Volumn 64, Issue 2, 2010, Pages 146-152

  Drakoularakou, A ^a   Tzortzis, G ^b   Rastall, R A ^a   Gibson, G R ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b Clasado Ltd   (United Kingdom)

Author keywords

Galacto oligosacharides; Prebiotics; Travellers' diarrhoea

Indexed keywords

BIMUNO; GALACTOSE OLIGOSACCHARIDE; MALTODEXTRIN; PLACEBO; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION HABIT; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FEMALE; FLATULENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TRAVELLER DIARRHEA; VOMITING;

ABDOMINAL PAIN; ADULT; DEFECATION; DIARRHEA; DOUBLE-BLIND METHOD; DYSENTERY; FECES; FEMALE; FLATULENCE; GASTROINTESTINAL AGENTS; HUMANS; INCIDENCE; MALE; OLIGOSACCHARIDES; PREBIOTICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TRAVEL; VOMITING;

EID: 76649125531     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2009.120     Document Type: Article

References (25)

1. Black RE (1990). Epidemiology of travellers' diarrhea and relative importance of various pathogens. Rev Infect Dis 12, S73-S79.
2. Buddington KK, Danohoo JB, Buddington RK (2002). Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumour inducers. J Nutr 132, 472-477.
3. Center for Disease Control and Prevention (CDC) (2008). Prevention of specific infectious diseases. In: CDC Health Information for International Travel. Atlanta, GA.
4. Cremonini F, Di Caro S, Nista EC (2002). Meta-analysis: the effect of probiotic administration on antibiotic associated diarrhea. Aliment Pharmacol Ther 16, 1461-1467.
5. Cummings JH, Christie S, Cole JT (2001). A study of fructooligosacharides in the prevention of travellers' diarrhea. Aliment Pharmacol Ther 15, 1139-1145.
6. Depeint F, Tzortzis G, Vulevic J, I'anson K, Gibson GR (2008). Prebiotic evaluation of a novel galacto-oligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIM 41171, in healthy humans. Am J Clin Nutr 87 (Suppl, 3), S785-S791.
7. DuPont HL (2001). Treatment of travellers' diarrhea. J Travel Med 8, S31-S33.
8. DuPont HL, Capsuto EG (1996). Persistent diarrhea in travellers. Clin Infect Dis 22, 124-128.
9. Gibson GR, McCartney AL, Rastall RA (2005). Prebiotics and resistance to gastrointestinal infections. Br J Nutr 93, S31-S34.
10. Gibson GR, Roberfroid MB (1995). Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401-1412.
11. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ (2002). Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47, 2625-2634.
12. Kamat D, Mathur A (2006). Prevention and management of travellers' diarrhea. Travel Med 52 (Suppl, 7), 289-302.
13. Kunz C, Rudloff S, Baier W, Klein N, Strobel S (2000). Oligosaccharides in human milk: structural functional, and metabolic aspects. Ann Rev Nutr 20, 699-722.
14. Paredes P, Campbell-Forrester S, Mathewson JJ, Ashley D, Thompson S, Steffen R et al. (2000). Etiology of travellers' diarrhea on a Caribbean Island. J Travel Med 7, 15-18.
15. Peltola H, Gorbach SL (2001). Travellers' diarrhea epidemiology and clinical aspects. In: Dupont H, Steffen R (eds). Textbook of Travel Medicine and Health. BC Decker Inc, Hamilton: Canada. pp 151-159.
16. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344, 1046-1049.
17. Searle LEJ, Best A, Nunez A, Salguero FJ, Johnson L,Weyer U et al. (2009). A galacto-oligosaccharide mixture, produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, reduces Salmonella Typhimurium infection in mice. J Med Microb 58, 37-48.
18. Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR (2009). Clinical trial: the effect of a trans-galactooligosacharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29, 508-518.
19. Steffen R, Van Der Linde F, Gyr K, Schär M (1983). Epidemiology of diarrhea in travellers. JAMA 249, 1176-1180.
20. Tojo M, Oikawa T, Morikawa Y, Yamashita N, Iwata S, Satoh Y (1987). The effects of Bifidobacterium breve administration on Campylobacter enteritis. Acta Pediatr Jpn 29, 160-167.
21. Tzortzis G, Goulas AK, Gee JM, Gibson GR (2005). A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colon of pigs in vivo. J Nutr 135, 1726-1731.
22. U.S. Food and Drug Administration (2008). Center for Food Safety and Applied Nutrition. Office of Food Additive Safety. Version 28 July, 2008. GRAS Notice No. CRN 000236. Internet: http:// www.cfsan.fda.gov/Brdb/opa-g236.html (accessed 06 November 2008).
23. Vila J, Vargas M, Ruiz J, Corachan M, Jimenez De Anta MT, Gascon J (2000). Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travellers to India in comparison with other geographical areas. Antimicrob Agents Chemother 44, 1731-1733.
24. Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR (2008). Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosacharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88, 1438-1446.
25. World Health Organization (2004). WHOQOL Study Protocol. WHO 2004 MNH7PSF/93.9.